相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An analysis of original research contributions toward FDA-approved drugs
Eric V. Patridge et al.
DRUG DISCOVERY TODAY (2015)
Experience With the Priority Review Voucher Program for Drug Development
Aaron S. Kesselheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
21st Century Cures Act wins in US House
[Anonymous]
NATURE BIOTECHNOLOGY (2015)
Incentives to Repurpose Existing Drugs for Orphan Indications
Annette K. Kwok et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases
Kristina Sachs-Barrable et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
The discovery of medicines for rare diseases
David C. Swinney et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
Marc Tardieu et al.
HUMAN GENE THERAPY (2014)
Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery
Jill Wood et al.
DRUG DISCOVERY TODAY (2013)
A generalizable pre-clinical research approach for orphan disease therapy
Chandree L. Beaulieu et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases
Brigitta E. Miyamoto et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Therapies for Inborn Errors of Metabolism: What Has the Orphan Drug Act Delivered?
Sonali S. Talele et al.
PEDIATRICS (2010)
Sanfilippo syndrome: A mini-review
M. J. Valstar et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
分享论文
